Literature DB >> 17229221

Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study.

T Yamamoto1, M Nakahigashi, S Umegae, T Kitagawa, K Matsumoto.   

Abstract

BACKGROUND: The impact of enteral nutrition on post-operative recurrence has not been properly examined. AIM: To investigate the impact of enteral nutrition using an elemental diet on clinical and endoscopic recurrence after resection for Crohn's disease.
METHODS: Forty consecutive patients who underwent resection for ileal or ileocolonic Crohn's disease were studied. After operation, 20 patients continuously received enteral nutritional therapy (EN group), and 20 had neither nutritional therapy nor food restriction (non-EN group). In the EN group, enteral formula (Elental) was infused through a nasogastric tube in the night-time, and low fat foods were taken in the daytime. All patients were followed up regularly for 1 year after operation. Ileocolonoscopy was performed at 6 and 12 months after operation.
RESULTS: One patient (5%) in the EN group and seven (35%) in the non-EN group developed clinical recurrence during 1-year follow-up (P = 0.048). Six months after operation, five patients (25%) in the EN group and eight (40%) in the non-EN group developed endoscopic recurrence (P = 0.50). Twelve months after operation, endoscopic recurrence was observed in six patients (30%) in the EN group and 14 (70%) in the non-EN group (P = 0.027).
CONCLUSIONS: Our long-term enteral nutritional therapy significantly reduced clinical and endoscopic recurrence after resection for Crohn's disease.

Entities:  

Mesh:

Year:  2007        PMID: 17229221     DOI: 10.1111/j.1365-2036.2006.03158.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  42 in total

Review 1.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

2.  Prevention of recurrence after surgery for Crohn's disease: efficacy of infliximab.

Authors:  Takayuki Yamamoto
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

Review 3.  Enteral nutrition for maintaining remission in patients with quiescent Crohn's disease: current status and future perspectives.

Authors:  Maki Nakahigashi; Takayuki Yamamoto; Rodolfo Sacco; Hiroyuki Hanai; Fumio Kobayashi
Journal:  Int J Colorectal Dis       Date:  2015-08-15       Impact factor: 2.571

Review 4.  Dietary management of IBD--insights and advice.

Authors:  Emma P Halmos; Peter R Gibson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

5.  Can nutritional therapy replace pharmacologic therapy in pediatric Crohn's disease?

Authors:  Miquel A Gassull
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-12-23

Review 6.  Managing medical complications and recurrence after surgery for Crohn's disease.

Authors:  Bo Shen
Journal:  Curr Gastroenterol Rep       Date:  2008-12

Review 7.  Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission.

Authors:  Douglas L Nguyen; Berkeley Limketkai; Valentina Medici; Mardeli Saire Mendoza; Lena Palmer; Matthew Bechtold
Journal:  Curr Gastroenterol Rep       Date:  2016-10

8.  Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn's disease.

Authors:  Takayuki Yamamoto; Maki Nakahigashi; Satoru Umegae; Koichi Matsumoto
Journal:  J Gastroenterol       Date:  2009-10-02       Impact factor: 7.527

Review 9.  Preoperative optimization of crohn disease.

Authors:  Amit Sharma; Bertram T Chinn
Journal:  Clin Colon Rectal Surg       Date:  2013-06

Review 10.  Postoperative Crohn's disease recurrence: a practical approach.

Authors:  Pilar Nos; Eugeni Domenech
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.